Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIONA: PI vs NNRTI in HIV-1
NCT01192035Phase 4Completed
- Sponsor
- Aarhus University
- Start
- May 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lopinavir + ritonavir in human immunodeficiency virus type 1 infection (HIV-1) (2 arms), sponsored by Aarhus University. Primary endpoint: Fraction of patients with viral load suppression <400 copies/ml at 12 months. Started May 2011; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01192035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192035.